Erika Hamilton, MD, breaks down liver monitoring, diarrhea, creatinine shifts, and oral adherence with maintenance tucatinib in HER2+ MBC.
|Articles|March 15, 2019
From Nurse to Patient and Back Again: Lessons Learned
Author(s)Brielle Benyon
Listen to the first-ever episode of the CURE Talks Cancer Podcast: Nursing Edition.
Advertisement
Patricia Jakel, RN, MN, AOCN, thought that she was doing perfectly fine in her career as an oncology nurse. Until she was diagnosed with breast cancer.
In the first-ever
Advertisement
Related to this article
ABUS matched handheld ultrasound on cancer detection in women with dense breasts while lowering recall and short-interval follow-up rates.
Two Winship nurses explain how to talk with breast cancer survivors about GLP-1 receptor agonists, from endocrine therapy to access barriers.
For MBC Awareness Day, an NP and a former ICU nurse living with metastatic breast cancer discuss repeat education, biomarker testing, and support.
Marieta Branis, APN, discusses individualized breast cancer care, monitoring for ADC and oral therapy toxicities, younger patients, and survivorship.
Real-time check-ins from patients with MBC showed quality of life dipped when depression, anxiety, or fatigue rose above usual levels.
FDA approves tucatinib maintenance with trastuzumab and pertuzumab for HER2+ breast cancer based on HER2CLIMB-05.
European survey reveals how oncology nurses manage complex multiple myeloma care amid time and resource constraints.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Patient Safety First: How a CNS Bridges Oncology Research and the Bedside
2
FDA Grants Accelerated Approval to Dostarlimab in dMMR Rectal Cancer
3
Anktiva Plus BCG: 84% of Responders Cystectomy-Free at 3 Years
4
Tucatinib Maintenance for HER2+ Breast Cancer: What Nurses, PAs Should Know
5